BioSpace News Archive

Munich/ Martinsried Medigene AG, a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, announces that Medigene’s researchers presented clinical immune monitoring data obtained during the first year of treatment from the ongoing Phase I/II clinical trial with Medigene’s DC vaccine for the treatment of acute myeloid leukemia at the 61st ASH Annual Meeting.

MagForce successfully hosted the second session of its practice-oriented, unique, multifaceted application training for the use of the NanoTherm therapy system in treating brain tumors

Start Codon cohort companies to receive One Nucleus membership benefits

Inceptua announced that Stefan Fraenkel has been appointed CEO effective 1 January 2020.

BioGenerator-backed company is first to manufacture digital health device in St. Louis

SureClinical, a global provider of innovative cloud solutions for the health sciences market announced its new cloud-based regulatory document management solution for clinical investigator sites, SureISF.

Study will evaluate the safety and efficacy of the combination of iTeos’ EOS100850 and Merck’s KEYTRUDA® (pembrolizumab)

Scientific collaboration to study the anti-inflammatory activity of gut beneficial bacteria, more specifically Christensenella for which LNC Therapeutics holds an exclusive worldwide license